Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 138th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
TBPH	THERAVANCE BIOPHARMA INC	$725.20M	6.90%	3.50%	11.49%	15.90%	0.90	6.71	100.00%	16.90%	55.25%
RIGL	RIGEL PHARMACEUTICALS INC	$669.06M	438.90%	57.00%	88.99%	124.70%	1.52	2.02	91.50%	36.50%	39.89%
BCRX	BIOCRYST PHARMACEUTICALS INC	$1.62B	N/A	-7.40%	22.20%	6.00%	-2.08	2.25	97.00%	-6.40%	11.15%
HALO	HALOZYME THERAPEUTICS INC	$8.93B	136.60%	26.40%	36.99%	27.90%	5.17	8.36	84.20%	47.30%	60.25%
AUPH	AURINIA PHARMACEUTICALS INC	$1.69B	16.70%	11.50%	15.80%	14.50%	0.50	5.23	89.50%	23.30%	25.77%
BMRN	BIOMARIN PHARMACEUTICAL INC	$10.20B	11.50%	9.20%	12.57%	15.10%	0.24	5.56	79.60%	21.50%	27.78%
MDXG	MIMEDX GROUP INC	$1.03B	16.20%	12.00%	17.68%	40.40%	0.34	4.39	81.50%	8.80%	11.70%
PBYI	PUMA BIOTECHNOLOGY INC	$230.32M	49.30%	18.20%	39.47%	61.20%	1.02	1.53	72.40%	16.40%	18.58%
CRMD	CORMEDIX INC	$857.98M	22.60%	17.00%	14.95%	53.00%	0.30	4.21	95.20%	20.80%	20.85%
KNSA	KINIKSA PHARMACEUTICALS INTERNATIONAL PLC	$2.71B	1.00%	0.80%	2.62%	4.30%	0.34	3.57	85.90%	0.90%	2.69%
MIRM	MIRUM PHARMACEUTICALS INC	$3.73B	-24.80%	-8.50%	-7.40%	-10.50%	1.85	3.13	79.00%	-13.60%	-10.02%
INVA	INNOVIVA INC	$1.23B	5.70%	3.00%	7.86%	9.00%	0.87	2.64	86.60%	10.40%	23.09%
NAGE	NIAGEN BIOSCIENCE INC	$772.01M	35.50%	23.80%	26.49%	199.80%	0.43	3.88	63.60%	15.20%	15.76%
GMAB	GENMAB A	$17.96B	24.70%	19.90%	30.06%	75.00%	0.22	6.22	94.40%	37.60%	52.88%
AKBA	AKEBIA THERAPEUTICS INC	$766.90M	N/A	-18.90%	-9.98%	-30.20%	11.62	2.23	68.00%	-24.50%	-11.82%
ONC	BEONE MEDICINES LTD	$36.60B	-5.10%	-3.00%	-2.23%	-4.10%	0.67	1.95	85.50%	-3.90%	-1.99%
XERS	XERIS BIOPHARMA HOLDINGS INC	$1.19B	N/A	-9.90%	-2.16%	-1.70%	-18.34	1.95	82.20%	-13.00%	-2.10%
INCY	INCYTE CORP	$16.24B	24.10%	15.80%	27.84%	62.90%	0.40	2.85	92.90%	19.00%	27.59%
LGND	LIGAND PHARMACEUTICALS INC	$3.24B	-9.20%	-8.10%	-9.15%	-17.30%	0.15	5.45	93.00%	-40.40%	-43.10%
XOMA	XOMA ROYALTY CORP	$457.64M	-15.30%	-5.60%	-2.21%	-2.40%	1.81	4.88	100.00%	-27.60%	-9.92%
TVTX	TRAVERE THERAPEUTICS INC	$2.05B	-717.90%	-30.70%	-43.16%	-26.40%	15.96	2.00	96.90%	-50.60%	-47.28%
ZYME	ZYMEWORKS INC	$1.11B	-31.60%	-24.00%	-29.74%	-33.70%	0.31	4.71	100.00%	-121.70%	-114.77%
ARQT	ARCUTIS BIOTHERAPEUTICS INC	$2.03B	-62.60%	-25.20%	-29.82%	-25.00%	1.54	3.20	89.10%	-35.40%	-28.13%
SLGL	SOL-GEL TECHNOLOGIES LTD	$66.80M	-10.20%	-8.40%	-9.93%	-14.20%	0.23	7.32	100.00%	-14.20%	-14.25%
ALNY	ALNYLAM PHARMACEUTICALS INC	$60.45B	-274.20%	-7.40%	-6.96%	-4.50%	17.22	2.80	83.60%	-13.00%	-9.23%
VRTX	VERTEX PHARMACEUTICALS INC	$100.82B	22.10%	15.90%	22.07%	31.10%	0.40	2.52	86.10%	31.90%	38.45%
DOMH	DOMINARI HOLDINGS INC	$90.84M	-36.60%	-30.20%	-20.49%	-35.90%	0.24	3.65	100.00%	-36.00%	-36.01%
IONS	IONIS PHARMACEUTICALS INC	$9.74B	-45.50%	-9.00%	-8.77%	-5.00%	3.73	2.87	98.90%	-28.40%	-19.40%
ABUS	ARBUTUS BIOPHARMA CORP	$868.40M	-59.20%	-44.10%	-55.10%	-68.90%	0.25	20.53	100.00%	-351.90%	-351.17%
VCYT	VERACYTE INC	$2.50B	2.80%	2.60%	2.83%	23.70%	0.10	5.10	68.00%	7.10%	7.57%
IMAB	I-MAB	$296.21M	-18.80%	-17.70%	-19.16%	-32.20%	0.05	22.82	N/A	N/A	N/A
CPRX	CATALYST PHARMACEUTICALS INC	$2.42B	27.50%	23.80%	31.66%	413.50%	0.14	6.71	85.80%	37.40%	48.70%
FBIO	FORTRESS BIOTECH INC	$105.63M	-87.40%	-15.80%	-0.19%	-0.40%	2.79	1.92	70.90%	-40.60%	-0.34%
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	$1.87B	26.30%	17.70%	25.99%	53.80%	0.43	3.84	78.30%	23.40%	31.22%
FHTX	FOGHORN THERAPEUTICS INC	$282.08M	N/A	-28.00%	-50.79%	-44.10%	-3.95	2.62	100.00%	-311.90%	-311.90%
LXRX	LEXICON PHARMACEUTICALS INC	$407.01M	-83.60%	-42.20%	-56.64%	-49.10%	0.74	4.17	99.20%	-206.40%	-184.91%
CORT	CORCEPT THERAPEUTICS INC	$7.33B	20.00%	16.10%	15.26%	17.50%	0.26	3.06	98.40%	18.40%	14.00%
FENC	FENNEC PHARMACEUTICALS INC	$241.30M	N/A	-24.70%	-23.30%	-24.30%	-7.01	4.85	89.90%	-36.10%	-25.51%
FOLD	AMICUS THERAPEUTICS INC	$2.38B	-19.80%	-4.80%	3.89%	3.80%	2.99	3.21	90.40%	-6.70%	4.41%
ACAD	ACADIA PHARMACEUTICALS INC	$4.13B	35.30%	21.70%	31.92%	64.00%	0.48	2.88	92.00%	23.00%	26.58%
ZVRA	ZEVRA THERAPEUTICS INC	$405.86M	4.00%	1.30%	13.14%	23.30%	1.19	7.85	72.00%	4.30%	48.18%
EXEL	EXELIXIS INC	$10.50B	27.70%	21.10%	33.12%	32.40%	0.32	3.51	96.60%	27.00%	34.78%
ASND	ASCENDIS PHARMA A	$11.81B	N/A	-33.40%	-107.48%	-42.00%	-6.59	1.04	85.30%	-92.70%	-51.29%
VCEL	VERICEL CORP	$1.59B	2.50%	1.70%	2.00%	2.00%	0.42	4.97	73.50%	2.90%	3.16%
RPRX	ROYALTY PHARMA PLC	$20.50B	10.20%	5.70%	7.52%	5.50%	0.93	1.26	100.00%	44.30%	55.83%
JAZZ	JAZZ PHARMACEUTICALS PLC	$7.60B	-10.00%	-3.50%	-3.40%	-4.00%	1.95	1.62	88.70%	-9.90%	-7.37%
ARGX	ARGENX SE	$46.19B	24.70%	21.40%	10.88%	20.20%	0.18	5.60	-19,733.10%	78,552.00%	40,946.87%
TGTX	TG THERAPEUTICS INC	$5.04B	26.10%	9.60%	18.37%	16.60%	1.54	3.86	87.00%	13.30%	21.47%
ATRA	ATARA BIOTHERAPEUTICS INC	$83.86M	-8.30%	6.60%	44.55%	25.20%	-2.05	1.70	81.20%	3.10%	5.27%
OVID	OVID THERAPEUTICS INC	$91.02M	-58.80%	-43.20%	-55.73%	-55.70%	0.39	4.72	100.00%	-574.00%	-574.02%
TECH	BIO-TECHNE CORP	$8.03B	3.60%	2.80%	4.49%	8.10%	0.33	3.46	64.80%	6.00%	8.77%
VALN	VALNEVA SE	$725.10M	-35.30%	-13.60%	-11.90%	-10.30%	1.54	2.27	49.00%	-34.10%	-21.03%
PTCT	PTC THERAPEUTICS INC	$4.67B	-71.70%	29.30%	39.40%	123.50%	-15.30	3.89	96.90%	33.60%	45.78%
MDGL	MADRIGAL PHARMACEUTICALS INC	$9.49B	-38.40%	-27.30%	-32.75%	-34.00%	0.46	5.11	96.30%	-54.70%	-52.01%
ASMB	ASSEMBLY BIOSCIENCES INC	$162.58M	-149.00%	-39.00%	-116.58%	-139.30%	3.46	1.64	N/A	N/A	N/A
FTRE	FORTREA HOLDINGS INC	$918.00M	-95.00%	-31.10%	-49.46%	-65.70%	3.81	1.02	19.70%	-37.60%	-34.25%
SPRO	SPERO THERAPEUTICS INC	$105.80M	-120.30%	-55.60%	-113.62%	-424.60%	0.89	3.98	100.00%	-110.30%	-110.34%
MESO	MESOBLAST LTD	$1.98B	-19.00%	-14.10%	-11.56%	-103.10%	0.31	1.99	70.20%	-593.90%	-458.45%
NTHI	NEONC TECHNOLOGIES HOLDINGS INC	$191.02M	N/A	N/A	N/A	N/A	-1.25	0.11	N/A	N/A	N/A
ADPT	ADAPTIVE BIOTECHNOLOGIES CORP	$1.99B	-60.90%	-23.00%	-27.07%	-22.50%	1.76	2.84	66.00%	-59.10%	-53.35%
APLS	APELLIS PHARMACEUTICALS INC	$3.08B	-116.10%	-26.70%	-29.03%	-24.10%	4.26	3.77	83.80%	-30.20%	-23.88%
REGN	REGENERON PHARMACEUTICALS INC	$60.69B	15.10%	11.80%	14.21%	14.80%	0.28	4.60	85.60%	31.40%	34.55%
IMCR	IMMUNOCORE HOLDINGS PLC	$1.73B	-5.90%	-2.10%	-0.47%	-0.50%	1.72	6.36	99.00%	-6.50%	-1.24%
PLX	PROTALIX BIOTHERAPEUTICS INC	$152.29M	14.70%	8.70%	16.88%	29.10%	0.57	2.72	57.50%	10.10%	14.82%
EVAX	EVAXION A	$18.44M	-320.20%	-63.60%	-59.92%	-74.40%	2.61	3.42	100.00%	-377.00%	-323.11%
INBX	INHIBRX BIOSCIENCES INC	$393.79M	-137.80%	-76.30%	-91.16%	-390.10%	2.09	4.98	100.00%	-11,692.40%	-11,275.86%
RCUS	ARCUS BIOSCIENCES INC	$1.23B	-56.00%	-25.70%	-33.64%	-35.90%	0.96	4.51	100.00%	-113.70%	-111.07%
BDTX	BLACK DIAMOND THERAPEUTICS INC	$181.39M	4.70%	3.50%	3.19%	5.20%	0.25	9.24	100.00%	7.30%	7.27%
GYRE	GYRE THERAPEUTICS INC	$760.87M	5.80%	3.10%	5.16%	7.40%	0.25	5.40	95.90%	4.10%	6.85%
ZYBT	ZHENGYE BIOTECHNOLOGY HOLDING LTD	$504.21M	4.10%	2.30%	4.56%	4.10%	0.50	1.31	49.00%	6.10%	8.73%
BNTX	BIONTECH SE	$23.53B	-1.80%	-1.60%	-1.65%	-3.50%	0.17	8.61	79.80%	-12.00%	-11.35%
KRYS	KRYSTAL BIOTECH INC	$4.51B	15.20%	13.80%	16.05%	26.50%	0.09	9.68	93.40%	40.80%	46.98%
SRPT	SAREPTA THERAPEUTICS INC	$1.71B	-4.40%	-1.60%	-0.87%	-0.60%	1.71	2.89	79.30%	-2.30%	-0.97%
ABEO	ABEONA THERAPEUTICS INC	$293.57M	77.70%	39.80%	36.32%	85.00%	0.51	6.73	100.00%	14,310.50%	19,223.25%
AAPG	ASCENTAGE PHARMA GROUP INTERNATIONAL	$3.37B	-161.90%	-37.80%	-60.39%	-50.70%	3.56	1.54	90.90%	-296.80%	-277.82%
AXSM	AXSOME THERAPEUTICS INC	$5.83B	-357.60%	-41.70%	-80.39%	-140.30%	7.76	1.57	91.50%	-49.90%	-48.34%
IRD	OPUS GENETICS INC	$82.07M	-366.70%	-142.10%	-315.46%	614.70%	1.21	1.90	100.00%	-377.90%	-377.89%
VRCA	VERRICA PHARMACEUTICALS INC	$46.66M	N/A	-115.50%	-400.01%	-132.00%	-3.24	1.26	86.50%	-330.50%	-268.91%
TARS	TARSUS PHARMACEUTICALS INC	$2.09B	-32.40%	-21.00%	-20.45%	-29.10%	0.49	5.26	93.40%	-31.10%	-28.01%
OKYO	OKYO PHARMA LTD	$78.61M	N/A	-180.40%	127.79%	102.70%	-1.66	0.40	N/A	N/A	N/A
SLNO	SOLENO THERAPEUTICS INC	$2.72B	-73.70%	-56.70%	-57.20%	-67.90%	0.38	15.13	97.90%	-554.50%	-545.40%
PTHS	PELTHOS THERAPEUTICS INC	$100.39M	N/A	-689.50%	131.48%	454.90%	-1.13	0.11	N/A	N/A	N/A
KZIA	KAZIA THERAPEUTICS LTD	$5.32M	N/A	-134.30%	-2,049.17%	330.20%	-0.85	0.21	100.00%	-1,134.80%	-1,145.67%
ENTA	ENANTA PHARMACEUTICALS INC	$159.48M	-89.00%	-27.30%	-33.61%	-29.90%	2.80	5.00	100.00%	-142.00%	-133.00%
MNKD	MANNKIND CORP	$1.65B	-32.60%	7.80%	22.86%	11.40%	-8.48	2.50	74.90%	10.90%	22.71%
NVO	NOVO NORDISK A S	$248.34B	77.90%	24.20%	51.26%	67.90%	1.87	0.78	83.90%	35.60%	45.13%
CVAC	CUREVAC NV	$1.21B	29.20%	25.10%	35.70%	90.50%	0.18	6.17	94.80%	37.90%	43.41%
RARE	ULTRAGENYX PHARMACEUTICAL INC	$2.79B	-245.10%	-37.70%	-52.36%	-32.40%	7.96	2.46	85.30%	-87.30%	-86.93%
ARWR	ARROWHEAD PHARMACEUTICALS INC	$3.96B	-46.00%	-12.50%	-5.81%	-4.80%	1.30	5.15	100.00%	-26.40%	-14.41%
CDTX	CIDARA THERAPEUTICS INC	$867.81M	-132.70%	-98.60%	-128.03%	831.10%	0.35	3.87	100.00%	-60,589.70%	-60,589.74%
MAZE	MAZE THERAPEUTICS INC	$1.02B	N/A	N/A	N/A	N/A	0.16	13.63	N/A	N/A	N/A
TCRX	TSCAN THERAPEUTICS INC	$95.90M	-63.80%	-40.50%	-50.02%	-56.20%	0.69	7.06	100.00%	-1,964.90%	-1,920.20%
PGEN	PRECIGEN INC	$1.07B	-1,156.80%	-108.40%	-158.28%	-224.80%	-2.93	2.71	-0.70%	-2,868.70%	-2,870.25%
ZLAB	ZAI LAB LTD	$3.46B	-33.30%	-23.30%	-29.14%	-151.50%	0.45	3.26	63.50%	-60.30%	-59.46%
GERN	GERON CORP	$810.28M	-32.00%	-16.30%	-12.13%	-10.20%	1.14	7.87	97.80%	-53.50%	-36.21%
NRSN	NEUROSENSE THERAPEUTICS LTD	$28.54M	N/A	-491.20%	1,710.60%	441.30%	-4.25	0.71	N/A	N/A	N/A
UTHR	UNITED THERAPEUTICS CORP	$18.23B	18.70%	16.50%	22.33%	31.40%	0.10	7.26	89.00%	40.40%	53.56%
MNPR	MONOPAR THERAPEUTICS	$336.20M	-41.80%	-39.50%	-33.11%	-198.40%	0.03	33.94	N/A	N/A	N/A
NAMS	NEWAMSTERDAM PHARMA CO NV	$2.72B	-24.60%	-22.60%	-21.28%	-324.10%	0.05	21.09	100.00%	-258.90%	-258.91%
LIXT	LIXTE BIOTECHNOLOGY HOLDINGS INC	$15.30M	-237.50%	-189.30%	-285.68%	1,253.10%	0.31	4.26	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Sep 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Theravance Biopharma (NASDAQ:TBPH)

Theravance Biopharma (NASDAQ:TBPH) is the #1 top biotech stock out of 637 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Theravance Biopharma (NASDAQ:TBPH) is: Value: B, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: C.

Theravance Biopharma (NASDAQ:TBPH) has a Due Diligence Score of 39, which is 16 points higher than the biotech industry average of 23.

TBPH passed 12 out of 33 due diligence checks and has average fundamentals. Theravance Biopharma has seen its stock return 77.34% over the past year, overperforming other biotech stocks by 127 percentage points.

Theravance Biopharma has an average 1 year price target of $25.67, an upside of 78.24% from Theravance Biopharma's current stock price of $14.40.

Theravance Biopharma stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Theravance Biopharma, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Rigel Pharmaceuticals (NASDAQ:RIGL)

Rigel Pharmaceuticals (NASDAQ:RIGL) is the #2 top biotech stock out of 637 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Rigel Pharmaceuticals (NASDAQ:RIGL) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Rigel Pharmaceuticals (NASDAQ:RIGL) has a Due Diligence Score of 40, which is 17 points higher than the biotech industry average of 23.

RIGL passed 13 out of 33 due diligence checks and has average fundamentals. Rigel Pharmaceuticals has seen its stock return 171.27% over the past year, overperforming other biotech stocks by 221 percentage points.

Rigel Pharmaceuticals has an average 1 year price target of $32.00, a downside of -14.21% from Rigel Pharmaceuticals's current stock price of $37.30.

Rigel Pharmaceuticals stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Rigel Pharmaceuticals, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Biocryst Pharmaceuticals (NASDAQ:BCRX)

Biocryst Pharmaceuticals (NASDAQ:BCRX) is the #3 top biotech stock out of 637 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Biocryst Pharmaceuticals (NASDAQ:BCRX) is: Value: B, Growth: A, Momentum: D, Sentiment: A, Safety: C, Financials: B, and AI: B.

Biocryst Pharmaceuticals (NASDAQ:BCRX) has a Due Diligence Score of 12, which is -11 points lower than the biotech industry average of 23. Although this number is below the industry average, our proven quant model rates BCRX as a "A".

BCRX passed 4 out of 33 due diligence checks and has weak fundamentals. Biocryst Pharmaceuticals has seen its stock lose -2.65% over the past year, overperforming other biotech stocks by 47 percentage points.

Biocryst Pharmaceuticals has an average 1 year price target of $17.13, an upside of 122.4% from Biocryst Pharmaceuticals's current stock price of $7.70.

Biocryst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Biocryst Pharmaceuticals, 37.5% have issued a Strong Buy rating, 50% have issued a Buy, 12.5% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 6 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Essa Pharma (NASDAQ:EPIX)

Essa Pharma (NASDAQ:EPIX) has an annual dividend yield of 880.74%, which is 753 percentage points higher than the biotech industry average of 127.91%.

Essa Pharma's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 9.11%, which is -119 percentage points lower than the biotech industry average of 127.91%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 2.48%, which is -125 percentage points lower than the biotech industry average of 127.91%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 37.2% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.46% in the last day, and down -1.01% over the last week. Atyr Pharma was the among the top losers in the biotechnology industry, dropping -83.17% yesterday.

aTyr Pharma shares are trading lower after the company announced topline results from its Phase 3 EFZO-FIT study of efzofitimod in pulmonary sarcoidosis did not meet its primary endpoint.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -16.15% in the past year. It has overperformed other stocks in the biotech industry by 34 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 84.13% in the past year. It has overperformed other stocks in the biotech industry by 134 percentage points.

3. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Incyte has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has gained 25.19% in the past year. It has overperformed other stocks in the biotech industry by 75 percentage points.

Are biotech stocks a good buy now?

55.4% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 81.39% over the next year.

2.11% of biotech stocks have a Zen Rating of A (Strong Buy), 4.43% of biotech stocks are rated B (Buy), 41.98% are rated C (Hold), 35.44% are rated D (Sell), and 16.03% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -100.7x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Theravance Biopharma (NASDAQ:TBPH)

2. Rigel Pharmaceuticals (NASDAQ:RIGL)

3. Biocryst Pharmaceuticals (NASDAQ:BCRX)

1. Essa Pharma (NASDAQ:EPIX)

2. Dominari Holdings (NASDAQ:DOMH)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Incyte (NASDAQ:INCY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2025)Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Theravance Biopharma (NASDAQ:TBPH)

2. Rigel Pharmaceuticals (NASDAQ:RIGL)

3. Biocryst Pharmaceuticals (NASDAQ:BCRX)

1. Essa Pharma (NASDAQ:EPIX)

2. Dominari Holdings (NASDAQ:DOMH)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Incyte (NASDAQ:INCY)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.